-
1h 1m 32sPart 2 | Session 4 Session 2.3: Practical Pearls Towards a More Advanced CTO Programme
-
56m 37sPart 2 | Session 5 Session 2.4: Live Cases and Discussion
-
56m 12s
-
45m 31sPart 2 | Session 7 BREAKOUT: Coronary Physiology in STEMI patients today: Why? When? How?
-
1h 32sPart 3 | Session 1 Session 3.1 & 3.2: Keynote & Controversies
-
59m 54sPart 3 | Session 2 Session 3.3: Live Cases and Discussion
-
51m 53s
-
1h 3m 33sPart 3 | Session 4 Session 3.4: Debates
-
47m
-
1h 1m 7sPart 1 | Session 1 Session 1.1: Next Level Structural Heart Interventions
-
1h 2m 19sPart 1 | Session 2 Session 1.2: Live Cases and Discussion
-
59m 47sPart 1 | Session 4 Session 1.3: Practical Perspectives in the Context of TAVI
-
1h 2m 44sPart 1 | Session 5 Session 1.4: Live Cases and Discussions
-
44m 31sPart 1 | Session 6 BREAKOUT: Current Data and Future Direction in LAAC
-
1h 1m 36sPart 2 | Session 1 Session 2.1: Strategies for Calcified Coronary Lesions Anno 2022
-
57m 43sPart 2 | Session 2 Session 2.2: Live Cases and Discussion
Following on from the success of 2021's inaugural edition, Transcatheter Interventions Online 2022 brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.
Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2022 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
Note, the live version of this session was CME accredited; this on-demand version is not.
Key Learning Objectives
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Coronary Heart Disease: High Risk & Complex PCI
Faculty Biographies
Ole De Backer
Interventional Cardiologist
Prof Ole De Backer is an internationally renowned interventional cardiologist working at Rigshospitalet, Copenhagen University Hospital, Denmark and is an expert in structural heart interventions – among others transcatheter heart valve interventions, percutaneous left atrial appendage closure and thoracic endovascular aortic repair. Special areas of interest are the development and adoption of a fully percutaneous, minimal invasive approach for different structural heart interventions and the use of advanced cardiac imaging tools for planning and guidance of these interventions. He is actively involved and leading several research projects in the field of transcatheter heart valves and percutaneous left atrial appendage closure.
Darren Mylotte
Consultant Cardiologist
Dr Darren Mylotte graduated from RCSI Medical School in 2001, obtained membership of the Royal College of Physicians in Ireland in 2004, and completed the Irish Cardiology Specialist Training Scheme. He and was conferred with a Doctor of Medicine (MD) thesis in 2010 by the Royal College of Surgeons in Ireland and has also undertaken a PhD thesis. N the subject of Transcatheter Aortic Valve Implantation (TAVI) at the world renowned ThoraxCentre in Rotterdam, The Netherlands.
Colum Owens
Consultant Cardiologist
Dr Colum Owens, MBBCH is a Consultant Cardiologist at Belfast Health & Social Care Trust. His research interests are Cardiology, Transcatheter Valve Intervention, Patent Foramen Ovale, Left Atrial Appendage Occlusion, Congenital Heart Disease.
Mark Spence
Prof Mark Spence graduated with honours in Medicine from Queens University Belfast in 1995 and progress to Membership of the Royal College of Physicians (Edinburgh) in 1998.
He trained in cardiology in Belfast and then completed subspecialty training in congenital heart disease as a fellow in the inaugural Adult Congenital Heart Disease programme at Guys & St Thomas’ and the Royal Brompton Hospital, London.
His MD thesis was awarded by Queens University Belfast in 2002. He then completed a fellowship in interventional cardiology at The Royal Jubilee Hospital, British Columbia, Canada before taking up a consultant cardiology post in 2007 at the Royal Victoria Hospital, Belfast Trust. He joined Mater Private Network in November 2021.